Get TB Screening Formupdated52012

Questions and Answers About Tuberculosis What is TB? ... Why is TB still a problem in the United States? ... How is TB spread? ... Who is at risk for getting TB? ... What is latent TB infection (LTBI)? ... What is TB disease? ... Who is at risk for developing TB Disease?

An IGRA is a blood test that can determine if a person has been infected with TB bacteria. An IGRA measures how strong a person's immune system reacts to TB bacteria by testing the person's blood in a laboratory.

The purpose of this tool is to identify adults with infectious tuberculosis (TB) to prevent them from spreading disease. Do not repeat testing unless there are new risk factors since the last negative test.

Background: Since 2011, WHO recommends a four-symptom screening rule to exclude active tuberculosis in people living with HIV before starting tuberculosis preventive treatment (ie, absence of current cough, weight loss, night sweats, or fever).

TST Documentation Requirements Name and signature of person administering test. Date and time test administered. Location of test (e.g., right forearm, left forearm, alternate site) Tuberculin manufacturer, lot number and expiration date.

TB screening is used to look for signs of TB germs in people who have been exposed to someone with active TB disease or who have a high risk of exposure. The screening can show whether you have TB germs in your body and need more testing. It does not show if you have a latent infection or active disease.

There are two kinds of tests used to detect TB bacteria in the body: the TB skin test (TST) and TB blood tests. A positive TB skin test or TB blood test only tells that a person has been infected with TB bacteria. It does not tell whether the person has latent TB infection (LTBI) or has progressed to TB disease.

Please answer the following questions: Have you ever had a positive TB skin test? Have you ever had close contact with anyone who was sick with TB? Have you ever been vaccinated with BCG? * The significance of the travel exposure should be discussed with a health care provider and evaluated.